GO:0140869 miRNA inhibitor activity via base-pairing: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140869 (miRNA inhibitor activity via base-pairing) describes a molecular function in which a RNA molecule, often a long non-coding RNA (lncRNA), directly base-pairs with a microRNA (miRNA) and blocks its ability to silence target mRNAs.
• This activity is a key layer of post-transcriptional gene regulation, acting as a natural 'sponge' or decoy that fine-tunes miRNA availability and downstream gene expression.
• The function is mediated by base-pairing complementarity between the inhibitor RNA and the miRNA seed region, preventing miRNA loading into the RNA-induced silencing complex (RISC).
• Dysregulation of miRNA inhibitor activity via base-pairing is implicated in cancer progression, metastasis, and other diseases where miRNA networks are perturbed.
• Studying this activity requires tools such as CRISPR knockout, knock-in, and overexpression models to dissect the causal roles of specific lncRNAs and miRNAs.
• EDITGENE provides end-to-end CRISPR services, including knockout, point mutation, knock-in, overexpression, and library screening, to accelerate research on this GO term.
Description
MicroRNAs (miRNAs) are small non-coding RNAs that guide the RNA-induced silencing complex (RISC) to complementary target mRNAs, leading to translational repression or degradation. The activity of miRNAs is tightly controlled at multiple levels, including by RNA molecules that base-pair with the miRNA and sequester it from its targets. This regulatory function is captured by the Gene Ontology term GO:0140869, miRNA inhibitor activity via base-pairing, which is defined as stopping, preventing, or reducing miRNA-mediated gene silencing by base-pairing with a target miRNA. Long non-coding RNAs (lncRNAs) are prominent examples of molecules that exert this activity, acting as miRNA sponges or decoys. Understanding GO:0140869 is essential because it represents a widespread mechanism of post-transcriptional regulation that influences diverse biological processes, from development to disease. For researchers, this term provides a framework to annotate and study how specific RNAs modulate miRNA function. The activity is not merely a passive sponge effect; it involves specific base-pairing interactions that can be regulated and can have profound effects on gene expression networks. In cancer, for example, lncRNAs that act as miRNA inhibitors can promote oncogenesis by sequestering tumor-suppressive miRNAs, thereby unleashing the expression of oncogenic targets. This makes the components of GO:0140869 attractive candidates for therapeutic intervention and biomarkers. The sections below detail the definition, mechanism, key genes, disease links, and research methods for studying this activity.
miRNA inhibitor activity via base-pairing At A Glance
| GO ID | GO:0140869 |
|---|---|
| GO term | miRNA inhibitor activity via base-pairing |
| Ontology | molecular_function |
| Synonym | miRNA sponge; miRNA inhibitor activity; base-pairing target-directed microRNA suppressor activity |
| Major function | Stops, prevents or reduces miRNA-mediated gene silencing by base-pairing with a target miRNA |
| Example mediator | Long non-coding RNAs (lncRNAs) |
| Mechanism | Base-pairing complementarity between inhibitor RNA and miRNA |
| Biological context | Post-transcriptional gene regulation; competing endogenous RNA (ceRNA) networks |
What Is GO:0140869?
GO:0140869, miRNA inhibitor activity via base-pairing, is a molecular function that reduces or eliminates the gene-silencing activity of a microRNA (miRNA) through direct base-pairing with that miRNA. This base-pairing typically occurs between a long non-coding RNA (lncRNA) or other RNA and the miRNA, preventing the miRNA from interacting with its mRNA targets or from being loaded into the RISC. The term is synonymous with miRNA sponge activity, miRNA binding involved in posttranscriptional gene silencing, and base-pairing target-directed microRNA suppressor activity. It is classified under the molecular_function ontology aspect.
Why Is miRNA inhibitor activity via base-pairing Important in Cell Biology?
GO:0140869 is important because it describes a fundamental mechanism by which cells modulate miRNA activity, influencing gene expression programs in development, homeostasis, and disease. Dysregulation of this activity can lead to aberrant miRNA function, contributing to cancer, cardiovascular disorders, and neurological diseases. Understanding this term helps researchers identify and characterize regulatory RNAs, design experiments to test their function, and develop therapeutic strategies that target miRNA-inhibitor interactions.
• Provides a molecular explanation for how lncRNAs and other RNAs act as competing endogenous RNAs (ceRNAs) to sequester miRNAs.
• Influences diverse signaling pathways, including PTEN/AKT and TGF-beta, by modulating miRNA availability.
• Plays a role in cancer progression, where miRNA sponges can promote proliferation, metastasis, and drug resistance.
• Affects immune responses, such as natural killer cell cytotoxicity, by regulating miRNAs like miR-140-3p.
• Contributes to metabolic and autophagy regulation, as shown for miR-99b-5p targeting mTOR/AR axis.
• Is a target for small-molecule drug design aiming to disrupt oncogenic noncoding RNA interactions.
• Helps explain inter-individual variability in miRNA function and disease susceptibility.
• Offers opportunities for CRISPR-based functional genomics to identify causal miRNA inhibitors.
• Enables the development of RNA-based therapeutics that mimic or inhibit sponge activity.
• Supports the annotation of lncRNA functions in public databases and systems biology models.
What Happens During miRNA inhibitor activity via base-pairing?
Recognition and Base-Pairing
In simple terms: The inhibitor RNA finds and sticks to the miRNA like a lock and key.
The first step in miRNA inhibitor activity via base-pairing is the specific recognition between the inhibitor RNA (e.g., a lncRNA) and the target miRNA. This recognition is driven by complementary base-pairing, often involving the miRNA seed region (nucleotides 2-8). The inhibitor RNA contains binding sites that are partially or fully complementary to the miRNA, allowing for stable interaction. This base-pairing is essential for the activity and distinguishes it from other modes of miRNA regulation.
Sequestration of miRNA
In simple terms: The miRNA is trapped by the inhibitor RNA and cannot do its job.
Once bound, the inhibitor RNA sequesters the miRNA, preventing it from interacting with its normal mRNA targets. This sequestration can occur in the cytoplasm or nucleus, depending on the localization of the inhibitor RNA. By titrating the miRNA away from RISC, the inhibitor RNA reduces the effective concentration of free miRNA available for gene silencing. This mechanism is often referred to as 'sponging' and is a hallmark of competing endogenous RNA (ceRNA) networks.
Impact on Gene Silencing
In simple terms: Because the miRNA is blocked, its target genes are expressed more.
The ultimate consequence of miRNA sequestration is the de-repression of miRNA target genes. Normally, miRNAs guide RISC to complementary sequences in target mRNAs, leading to translational repression or mRNA degradation. When a miRNA inhibitor via base-pairing is active, this silencing is reduced or abolished, resulting in increased protein levels of the target genes. This can have broad effects on cellular pathways, depending on which miRNAs and targets are involved.
Regulation of Inhibitor RNA Levels
In simple terms: The amount of the inhibitor RNA itself can go up or down, changing the effect.
The activity of miRNA inhibitors via base-pairing is itself subject to regulation. The expression levels of the inhibitor RNA (e.g., lncRNA) can be modulated by transcription factors, epigenetic modifications, or other RNAs. Additionally, the inhibitor RNA may be subject to degradation or processing, affecting its availability to bind miRNAs. This dynamic regulation allows cells to fine-tune miRNA activity in response to developmental or environmental cues.
Crosstalk with Other RNA-Binding Proteins
In simple terms: Other proteins can join in and change how well the inhibitor works.
RNA-binding proteins (RBPs) can modulate the interaction between the inhibitor RNA and the miRNA. For example, RBPs may stabilize or destabilize the base-paired duplex, or they may compete for binding sites. This adds another layer of complexity to miRNA inhibitor activity via base-pairing, integrating it with broader RNA regulatory networks.
Key Genes Involved in GO:0140869 miRNA inhibitor activity via base-pairing
The following genes and non-coding RNAs are representative examples of molecules involved in or regulated by miRNA inhibitor activity via base-pairing (GO:0140869), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAS6-AS2 | lncRNA that acts as a miRNA sponge for miR-298 | Promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis |
| miR-298 | miRNA target of GAS6-AS2 sponge | Its sequestration by GAS6-AS2 leads to CDK9 upregulation |
| CDK9 | Cyclin-dependent kinase 9, downstream target of miR-298 | Involved in transcriptional regulation and cancer progression |
| PTEN | Tumor suppressor, target of miR-620 | Modulated by miRNA inhibitor activity in airway smooth muscle cells |
| AKT | Serine/threonine kinase, downstream of PTEN | Affected by miRNA sponge activity in TGF-beta1 signaling |
| mTOR | Kinase, target of miR-99b-5p | Regulated by miRNA inhibitor activity, impacting autophagy and prostate cancer |
| AR | Androgen receptor, target of miR-99b-5p | Involved in prostate cancer cell proliferation |
| MAPK1 | Mitogen-activated protein kinase 1, target of miR-140-3p | Modulates natural killer cytotoxicity in ovarian cancer |
| miR-140-3p | miRNA that can be inhibited by base-pairing | Its inhibition affects NK cytotoxicity via MAPK1 |
| miR-620 | miRNA involved in PTEN/AKT signaling | Its activity can be modulated by sponge RNAs |
| miR-99b-5p | miRNA targeting mTOR/AR | Its inhibition induces autophagy and inhibits prostate cancer proliferation |
| PRC2 complex | Polycomb repressive complex 2, regulated by AZD9291 | Involved in epigenetic silencing, potentially interacting with miRNA pathways |
| ARGONAUTE 1 | Core component of RISC | Required for miRNA function; its membrane association is affected by isoprenoid biosynthesis |
| MutLalpha | Mismatch repair protein complex | Modulates microRNA processing |
| Oncogenic noncoding RNAs | Small molecules can target them | Rational design of small molecules targeting oncogenic noncoding RNAs |
| miR-298 | miRNA sponge target | Sequestration by GAS6-AS2 promotes cancer |
| miR-140-3p | miRNA involved in NK cytotoxicity | Its inhibition via base-pairing could affect immune surveillance |
| miR-620 | miRNA in TGF-beta1 signaling | Potential target for sponge-based regulation |
How Is miRNA inhibitor activity via base-pairing Regulated?
The activity of miRNA inhibitors via base-pairing is regulated at multiple levels. The expression of the inhibitor RNA (e.g., lncRNA) is controlled by transcription factors and epigenetic mechanisms. Additionally, the stability and localization of the inhibitor RNA can be influenced by RNA-binding proteins and cellular signaling pathways. For instance, isoprenoid biosynthesis affects membrane association of ARGONAUTE 1, which is required for miRNA function and could indirectly impact miRNA inhibitor activity. Mismatch repair protein MutLalpha modulates microRNA processing, suggesting crosstalk between DNA repair and miRNA regulation. Furthermore, the PRC2 complex, which can be inactivated by drugs like AZD9291, may influence miRNA expression and thus the availability of miRNAs for inhibition. These regulatory layers ensure that miRNA inhibitor activity is dynamically controlled in response to cellular conditions.
miRNA inhibitor activity via base-pairing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GAS6-AS2 | Bladder cancer proliferation and metastasis | Knockout of GAS6-AS2 in bladder cancer cell lines; overexpression in normal cells |
| miR-99b-5p | Prostate cancer, autophagy | Overexpression or knockout of miR-99b-5p in prostate cancer cells |
| miR-140-3p | Ovarian cancer, NK cytotoxicity | Knockout or overexpression in NK cells and ovarian cancer co-culture models |
| miR-620 | Airway smooth muscle proliferation, asthma | Overexpression or inhibition in airway smooth muscle cells |
| PTEN/AKT pathway | TGF-beta1 signaling, airway remodeling | CRISPR knock-in of PTEN mutations in airway smooth muscle cells |
Cancer
Dysregulation of miRNA inhibitor activity via base-pairing is frequently observed in cancer. For example, the lncRNA GAS6-AS2 acts as a sponge for miR-298, leading to upregulation of CDK9 and promoting bladder cancer proliferation and metastasis. Similarly, miR-99b-5p targets mTOR/AR axis, and its inhibition can induce autophagy and inhibit prostate cancer cell proliferation. In ovarian cancer, miR-140-3p inhibition affects natural killer cytotoxicity via MAPK1, potentially impacting immune evasion. These examples highlight how miRNA sponges can contribute to oncogenesis and represent potential therapeutic targets.
Airway Remodeling and Asthma
In airway smooth muscle cells, miRNA-620 promotes TGF-beta1-induced proliferation by controlling PTEN/AKT signaling. This suggests that miRNA inhibitor activity via base-pairing could modulate airway remodeling in asthma and other respiratory diseases. By sequestering miR-620, sponge RNAs could enhance PTEN/AKT signaling and influence cell proliferation.
Metabolic and Autophagy Regulation
miR-99b-5p targets mTOR/AR axis and induces autophagy, inhibiting prostate cancer cell proliferation. This links miRNA inhibitor activity to metabolic pathways and autophagy, which are relevant to cancer and metabolic disorders. Modulating this activity could provide therapeutic strategies for diseases where autophagy is dysregulated.
Neurological and Developmental Disorders
While direct evidence for GO:0140869 in neurological diseases is limited in the provided citations, the general principle of miRNA sponges affecting gene expression networks suggests potential roles in neurodevelopment and neurodegeneration. Further research is needed to establish specific links.
From miRNA inhibitor activity via base-pairing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of a candidate lncRNA sponge increase free miRNA levels? | CRISPR knockout of the lncRNA in cancer cell lines, followed by miRNA quantification |
| Does a point mutation in the miRNA binding site abolish sponge activity? | CRISPR point mutation of the miRNA response element in the lncRNA |
| Can knock-in of a miRNA binding site confer sponge activity to a non-sponge RNA? | CRISPR knock-in of tandem miRNA binding sites into a control RNA |
| Does overexpression of a miRNA sponge affect target gene expression? | CRISPR activation (CRISPRa) or lentiviral overexpression of the sponge RNA |
| What is the global impact of a miRNA sponge on gene expression? | RNA-seq after knockout or overexpression of the sponge |
| Can small molecules disrupt miRNA-sponge interactions? | High-throughput screening with reporter assays in cells expressing the sponge |
How to Study the miRNA inhibitor activity via base-pairing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify de-repressed targets after sponge knockout |
| Small RNA-seq | miRNA abundance and identity | Confirm sequestration of specific miRNAs |
| Luciferase reporter assay | miRNA activity on a target site | Validate sponge-mediated relief of repression |
| RNA immunoprecipitation (RIP) | miRNA-RISC association | Test if sponge prevents miRNA loading into RISC |
| CRISPR knockout screen | Loss-of-function phenotypes | Discover novel miRNA inhibitor RNAs |
| CRISPR activation screen | Gain-of-function phenotypes | Identify sponge RNAs whose overexpression affects growth |
| Proteomics | Protein level changes | Measure de-repression of miRNA target proteins |
| Fluorescence in situ hybridization (FISH) | Localization of sponge RNA and miRNA | Visualize co-localization in cells |
RNA Sequencing (RNA-seq)
RNA-seq is used to measure global changes in gene expression upon modulation of miRNA inhibitor activity. By comparing transcriptomes of cells with knockout or overexpression of a candidate sponge RNA, researchers can identify de-repressed miRNA targets and affected pathways.
Small RNA Sequencing
Small RNA-seq quantifies miRNA levels and can detect changes in free miRNA abundance when sponge activity is altered. This helps confirm that the inhibitor RNA sequesters specific miRNAs.
Luciferase Reporter Assays
Luciferase reporters containing miRNA binding sites are used to measure miRNA activity. Co-expression of a candidate sponge RNA should relieve repression of the reporter, confirming miRNA inhibitor activity via base-pairing.
RNA Immunoprecipitation (RIP)
RIP with antibodies against RISC components (e.g., Argonaute) can assess whether a miRNA is loaded into RISC. If a sponge RNA prevents loading, RIP signals for the miRNA decrease.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify lncRNAs or other RNAs that act as miRNA inhibitors. Cells are selected for a phenotype (e.g., proliferation), and sgRNAs enriched in the population point to candidate regulators.
How CRISPR Can Be Used to Study GO:0140869 miRNA inhibitor activity via base-pairing
Knockout
CRISPR knockout is used to delete the genomic locus of a candidate miRNA inhibitor RNA (e.g., a lncRNA). This loss-of-function approach tests whether the RNA is necessary for sequestering a miRNA and regulating downstream targets. For example, knocking out GAS6-AS2 in bladder cancer cells can reduce proliferation and metastasis, confirming its oncogenic sponge role.
Point Mutation
CRISPR point mutation introduces precise changes in the miRNA binding site of the inhibitor RNA. This allows researchers to test the requirement of specific base-pairing interactions for the inhibitor activity. Mutating the seed match should abolish the sponge effect without affecting other functions of the RNA.
Knock-in
CRISPR knock-in can insert miRNA binding sites into a control RNA or tag the endogenous inhibitor RNA with a reporter. This helps to ectopically confer sponge activity or to track the RNA's localization and interaction with miRNAs.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to increase the levels of a candidate miRNA inhibitor RNA. This gain-of-function approach tests whether elevated sponge levels are sufficient to de-repress miRNA targets and alter cellular phenotypes.
How EDITGENE Supports miRNA inhibitor activity via base-pairing Research
Researchers studying miRNA inhibitor activity via base-pairing-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and efficiency.
Contact EDITGENE today to design your custom CRISPR model for miRNA inhibitor activity via base-pairing research.
Frequently Asked Questions About miRNA inhibitor activity via base-pairing
What is miRNA inhibitor activity via base-pairing?
It is a molecular function (GO:0140869) where an RNA molecule, such as a lncRNA, base-pairs with a miRNA and prevents it from silencing its target genes.
What genes are involved in miRNA inhibitor activity via base-pairing?
Genes include lncRNAs like GAS6-AS2, and miRNAs such as miR-298, miR-99b-5p, miR-140-3p, and miR-620, as well as their downstream targets like CDK9, mTOR, AR, and MAPK1 [3,4,6,8].
How does miRNA sponging work?
A sponge RNA contains multiple binding sites for a miRNA; when it binds, the miRNA is sequestered and cannot interact with its normal mRNA targets, leading to de-repression of those targets.
What is the role of GO:0140869 in cancer?
Dysregulated miRNA inhibitor activity can promote cancer by sequestering tumor-suppressive miRNAs, leading to overexpression of oncogenes. For example, GAS6-AS2 sponges miR-298 to promote bladder cancer.
Which diseases are associated with miRNA inhibitor activity via base-pairing?
It is implicated in various cancers (bladder, prostate, ovarian), airway remodeling in asthma, and potentially metabolic and neurological disorders [3,4,6,8].
How can CRISPR be used to study miRNA inhibitor activity?
CRISPR knockout can delete the sponge RNA, point mutations can disrupt miRNA binding sites, knock-in can add binding sites, and overexpression can increase sponge levels to test function [7,8].
What methods are used to measure miRNA inhibitor activity?
Common methods include luciferase reporter assays, RNA-seq, small RNA-seq, RNA immunoprecipitation, and CRISPR screens [7,8].
What is an example of a miRNA sponge in cancer?
The lncRNA GAS6-AS2 acts as a sponge for miR-298, leading to upregulation of CDK9 and promoting bladder cancer proliferation and metastasis.
Can small molecules target miRNA inhibitor activity?
Yes, rational design of small molecules targeting oncogenic noncoding RNAs is an emerging area, as demonstrated by Disney et al..
How does EDITGENE support research on miRNA inhibitor activity?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study this activity in various models.
Conclusion
GO:0140869, miRNA inhibitor activity via base-pairing, represents a crucial layer of post-transcriptional gene regulation with broad implications for cellular physiology and disease. The activity, mediated by RNAs such as lncRNAs that sponge miRNAs, fine-tunes gene expression networks and is frequently dysregulated in cancer and other disorders. Understanding the mechanisms and key players of this activity can reveal new therapeutic targets and biomarkers. With advanced CRISPR tools and services from EDITGENE, researchers are well-equipped to dissect the causal roles of specific miRNA inhibitors and translate these findings into clinical applications.
References
- 1. Zhang KL et al.. 2019. AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition.. Acta Pharmacol Sin 40(12):1587-1595 PMID: 31171828
- 2. Brodersen P et al.. 2012. Isoprenoid biosynthesis is required for miRNA function and affects membrane association of ARGONAUTE 1 in Arabidopsis.. Proc Natl Acad Sci U S A 109(5):1778-83 PMID: 22247288
- 3. Niture S et al.. 2022. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.. Tumour Biol 44(1):107-127 PMID: 35811549
- 4. Wang J et al.. 2020. MiR-140-3p inhibits natural killer cytotoxicity to human ovarian cancer via targeting MAPK1.. J Biosci 45 PMID: 32385217
- 5. Mao G et al.. 2012. Modulation of microRNA processing by mismatch repair protein MutLα.. Cell Res 22(6):973-85 PMID: 22290424
- 6. Chen H et al.. 2020. MiRNA-620 promotes TGF-β1-induced proliferation of airway smooth muscle cell through controlling PTEN/AKT signaling pathway.. Kaohsiung J Med Sci 36(11):869-877 PMID: 32583575
- 7. Disney MD et al.. 2016. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.. Acc Chem Res 49(12):2698-2704 PMID: 27993012
- 8. Rui X et al.. 2019. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.. J Cell Mol Med 23(2):865-876 PMID: 30394665
